BioCentury
ARTICLE | Distillery Therapeutics

Zelboraf-based PROTAC for melanoma, lung cancer expressing BRAF mutations

February 26, 2021 10:04 PM UTC

DISEASE CATEGORY: Cancer

INDICATION: Melanoma; lung cancer...

BCIQ Company Profiles

Yale University